NHS National Generic Pharmaceuticals Wave 15b

NHS National Pharmaceuticals Generic Products – Wave 15b<br/>Offer reference number: CM/PHG/23/5698<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) for a period or periods up to a total of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>CM/PHG/23/5698/01 – Orals (plus non-parenteral) Products<br/>CESW: (Midlands and Southwest): 1st October 2025 to 31st May 2027 (20 months)<br/>NWLN: (Northwest and London North): 1st October 2025 to 31st May 2027 (20 months)<br/>LSNE: (London South and Northeast): 1st October 2025 to 31st May 2027 (20 months)<br/><br/>CM/PHG/23/5698/02 – Hospital Only Products<br/>DCE (Midlands) & DSW (Southwest): 1st October 2025 to 30th September 2027 (24 months)<br/><br/>CM/PHG/23/5698/03 – Hospital Only (Housekeeping) Products<br/>DLS (London South) & DNE (Northeast): 1st October 2025 to 31st May 2026 (8 months)<br/>DNW (Northwest) & DLN (London North): 1st October 2025 to 31st January 2027 (16 months)<br/>DCE (Midlands) & DSW (Southwest): 1st October 2025 to 31st May 2026 (8 months)